Nasal Drug Delivery Technology

Global Market Trajectory & Analytics

MCP13533

EXECUTIVE ENGAGEMENTS

POOL

4872
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

877
Interactions with Platform & by Email

PARTICIPANTS

146
Unique # Participated

VALIDATIONS

42
Responses Validated*

COMPANIES

47
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

201

PAGES

278

EDITION

7

PRICE

USD 5450

CODE

MCP13533


COMPETITIVE METRICS

COMPANY

D S N T

% *

3M Company

AptarGroup, Inc.

AstraZeneca PLC

Brother Industries Limited

Comestero Sistemi S.P.A.

Dr. Korman Laboratories Ltd.

ERBAGIL srl

Genmed Group Limited

GlaxoSmithKline PLC

Johnson & Johnson Services, Inc.

*Login to Participate & View Data Stacks
View 47 Companies...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Nasal Drug Delivery Technology estimated at US$51.6 Billion in the year 2020, is projected to reach a revised size of US$73.3 Billion by 2027, growing at a CAGR of 5.1% over the analysis period 2020-2027. Nasal Sprays, one of the segments analyzed in the report, is projected to record a 6.2% CAGR and reach US$40 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Drops & Liquids segment is readjusted to a revised 4.4% CAGR for the next 7-year period.
The Nasal Drug Delivery Technology market in the U.S. is estimated at US$15.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$12.9 Billion by the year 2027 trailing a CAGR of 4.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5% and 4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.
In the global Other Dosage Forms segment, USA, Canada, Japan, China and Europe will drive the 2.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$4.2 Billion in the year 2020 will reach a projected size of US$5 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$8.4 Billion by the year 2027.

SELECT PLAYERS

3M Company; Aegis Therapeutics LLC; Aptargroup, Inc.; AstraZeneca PLC; GlaxoSmithKline PLC; Johnson & Johnson; Merck & Co., Inc.; Novartis International AG; Pfizer, Inc.

SEGMENTS

» Dosage Form (Nasal Sprays, Drops & Liquids, Other Dosage Forms) » End-Use (Home Care Settings, Hospitals) » System (Multi-dose, Unit-dose, Bi-dose) » Therapeutic Application (Allergic And Non-allergic Rhinitis, Nose Congestion, Vaccination, Other Therapeutic Applications)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Nasal Drug Delivery Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Nasal Drug Delivery Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Nasal Drug Delivery Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Nasal Sprays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Nasal Sprays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Nasal Sprays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Drops & Liquids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Drops & Liquids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Drops & Liquids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Dosage Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Other Dosage Forms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Dosage Forms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Multi-dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Multi-dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Multi-dose by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Unit-dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Unit-dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Unit-dose by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Bi-dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Bi-dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Bi-dose by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Allergic & Non-allergic Rhinitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Allergic & Non-allergic Rhinitis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Allergic & Non-allergic Rhinitis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Nose Congestion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Nose Congestion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Nose Congestion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Vaccination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Vaccination by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Therapeutic Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Other Therapeutic Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Therapeutic Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Home Care Settings by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Home Care Settings by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
USA Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2012, 2020 & 2027
China Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2012, 2020 & 2027
China Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2012, 2020 & 2027
China Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
China Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for Nasal Drug Delivery Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
Europe Historic Review for Nasal Drug Delivery Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Nasal Drug Delivery Technology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2012, 2020 & 2027
France Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2012, 2020 & 2027
France Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2012, 2020 & 2027
France Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
France Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
UK Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2012, 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Nasal Drug Delivery Technology by Dosage Form - Nasal Sprays, Drops & Liquids and Other Dosage Forms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Nasal Drug Delivery Technology by Dosage Form - Percentage Breakdown of Value Sales for Nasal Sprays, Drops & Liquids and Other Dosage Forms for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Nasal Drug Delivery Technology by System - Multi-dose, Unit-dose and Bi-dose Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Nasal Drug Delivery Technology by System - Percentage Breakdown of Value Sales for Multi-dose, Unit-dose and Bi-dose for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Nasal Drug Delivery Technology by Therapeutic Application - Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Nasal Drug Delivery Technology by Therapeutic Application - Percentage Breakdown of Value Sales for Allergic & Non-allergic Rhinitis, Nose Congestion, Vaccination and Other Therapeutic Applications for the Years 2012, 2020 & 2027
Rest of World Current & Future Analysis for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
Rest of World Historic Review for Nasal Drug Delivery Technology by End-Use - Home Care Settings and Hospitals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
Rest of World 15-Year Perspective for Nasal Drug Delivery Technology by End-Use - Percentage Breakdown of Value Sales for Home Care Settings and Hospitals for the Years 2012, 2020 & 2027
Total Companies Profiled: 47

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com